Current on COVID-19

Three Tips for Successful Digital Companion Programs

As COVID-19 accelerated the use of digital companions, pharma now has a glimpse into ...

Best Laid Plans: 3 Obstacles to Prepare for in Your State Licensing Strategy

As the pandemic creates unique working and regulatory situations from state to state, manufacturers ...

Supporting Pharma Sales’ Journey Towards Greater Virtualization

The COVID-19 pandemic has forced many businesses to rethink how they reach their customers—and ...

Rise and Thrive: Six Imperatives for Healthcare Leadership During COVID-19

Five months of pandemic observation offers some initial clarity around the healthcare market landscape. ...

Reinforcing Racial and Gender Diversity in Clinical Trials

As the coronavirus pandemic continues, we are witnessing some of the fastest and most ...

Survey of NPs and PAs Reveal How Pharma Can Offer More Support During COVID

For many nurse practitioners (NPs) and physician assistants (PAs), the COVID-19 pandemic led to ...